NeuroPace, Inc.
NPCE
$8.42
-$0.14-1.64%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Net Income | -25.94M | -24.81M | -27.14M | -28.09M | -29.90M |
Total Depreciation and Amortization | 1.84M | 1.81M | 1.77M | 1.73M | 1.67M |
Total Amortization of Deferred Charges | 200.00K | 199.00K | 228.00K | 255.00K | 282.00K |
Total Other Non-Cash Items | 12.55M | 12.07M | 12.65M | 12.86M | 13.49M |
Change in Net Operating Assets | -4.73M | -7.18M | -5.45M | -3.25M | -2.62M |
Cash from Operations | -16.09M | -17.90M | -17.95M | -16.49M | -17.07M |
Capital Expenditure | -344.00K | -239.00K | -306.00K | -299.00K | -208.00K |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | 3.50M | 6.80M | 9.30M | 10.80M | 13.50M |
Cash from Investing | 3.16M | 6.56M | 8.99M | 10.50M | 13.29M |
Total Debt Issued | 58.57M | -- | -- | -- | -- |
Total Debt Repaid | -60.51M | -- | -- | -- | -- |
Issuance of Common Stock | 74.99M | 75.37M | 5.21M | 12.71M | 9.75M |
Repurchase of Common Stock | -50.11M | -50.01M | -881.00K | -826.00K | -793.00K |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -- | -- | -- | -186.00K | -186.00K |
Cash from Financing | 22.95M | 25.36M | 4.33M | 11.69M | 8.77M |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 10.01M | 14.02M | -4.63M | 5.70M | 4.99M |